F 0580
Level of Harm - Minimal harm
or potential for actual harm
Immediately tell the resident, the resident's doctor, and a family member of situations (injury/decline/room,
etc.) that affect the resident.
Based on record review and interview, the facility failed to notify the resident representative when there was
a change in condition for 1 of 3 residents reviewed for wound care, Resident #2.
Residents Affected - Few
Findings include:
Review of Resident #2's physician order dated 1/13/2023 reads, Mupirocin External Ointment 2%
(Mupirocin) apply to g-tube [gastrostomy tube] site topically every shift for infected g-tube site applied to
g-tube site after cleaning water and soap and pat dry then applied t-sponge.
Review of Resident #2's physician order dated 2/27/2023 reads, Triple Antibiotic External Ointment
(Neomycin-Bacitracin-Polymyxin) apply to g-tube site topically three times a day for infection of site with
foam dressing.
Review of Resident #2's physician order dated 2/27/2023 reads, Contact isolation precautions x [times] 10
days for ESBL (Extended Spectrum Beta-Lactamase) e-coli [Escherichia Coli] around G-tube every shift for
infection control and resolution for 10 days.
Review of Resident #2's physician order dated 2/27/2023 reads, Invanz Injection Solution Reconstituted 1
GM [gram] (Ertapenem Sodium) Inject 1 gram intramuscularly one time a day for g-tube infection for 7 days.
Review of Resident #2's physician order dated 2/27/2023 reads, Levaquin Oral Tablet 500 MG [milligrams]
(Levofloxacin) Give 1 tablet via G-Tube one time a day for g-tube infection for 7 days.
Review of Resident #2's progress note dated 2/27/2023 reads, [Advanced Practice Registered Nurse's
Name] aware of wound culture results. Resident on contact isolation.
Review of Resident #2's progress note dated 2/21/2023 reads, Optum APRN [Advanced Practice
Registered Nurse] [APRN's name] notified of G tube site draining pus, greenish color. She ordered to do
wound culture. Stat CBC [Complete Blood Count] and BMP [Basic Metabolic Panel]. Continue Nystatin to
armpit for another 5 days. She will come and see her.
Review of Resident Infection Report dated 2/28/2023 for Resident #2 reads, Infection site: G-tube site
infection, pus present at a wound, skin, or soft tissue site (green pus) . Evaluation . Healthcare acquired:
Symptoms were not present at the time of admission and resident meets McGeer's criteria for LTC [Long
Term Care] infections . Comments: Resident has chronic g-tube site infections. Culture was positive for
e-coli (ESBL) and pseudomonas aeruginosa. Resident has been placed on contact
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
105717
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105717
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/13/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Timberridge Nursing & Rehabilitation Center
9848 SW 110th St
Ocala, FL 34481
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0580
precautions.
Level of Harm - Minimal harm
or potential for actual harm
Review of Lab Results Report for Wound Culture 1 dated 2/25/2023 for Resident #2 reads, Final Report:
Site: G-Tube Site . Result: Escherichia coli (Isolate 1) . Result: Pseudomonas aeruginosa (Isolate 2).
Residents Affected - Few
Review of Resident #2's medical records revealed no evidence indicating that the resident representative
was notified of the change in the resident's condition.
During an interview on 10/13/2023 at 1:02 PM, the Wound Care Nurse stated, I am new to facility, worked
for a month now. Family should always be contacted if there is a change in the wound. I would document if I
contacted the family in my evaluation notes, or on the evaluation form.
During an interview on 10/13/2023 at 2:30 PM, the Administrator stated, I believe to notify the family for
changes in level of care. I think for a new onset in condition potentially for someone who has had a chronic
ongoing infection. Isolation is a nursing procedure but not the treatment which would be the same.
During an interview on 10/13/2023 at 2:35 PM, the Director of Nursing/Risk Manager stated, I do believe
with a resident is placed on isolation, family should be contacted. I mean it is a change in the resident
condition.
Review of the facility policy and procedure titled Change in a Resident Condition or Status with the last
review date of 12/20/2022 reads, Policy: The facility shall promptly notify the resident, his or her Attending
Physician, and representative of changes in the resident's medical/mental condition and/or status (e.g.,
changes in level of care, billing/payments, resident rights, etc.) . Procedure . 3. Unless otherwise instructed
by the resident, the Nurse Supervisor/Charge Nurse/Designee will notify the resident's family or
representative when . There is a significant change in the residents physical, mental, or psychosocial
status.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105717
If continuation sheet
Page 2 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105717
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/13/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Timberridge Nursing & Rehabilitation Center
9848 SW 110th St
Ocala, FL 34481
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review and interview, the facility failed to develop a comprehensive person-centered care plan for 1
of 3 residents reviewed for diabetes, Resident #1.
Finding include:
Review of Resident #1's admission record showed the resident was most recently admitted on [DATE] with
diagnoses to include type 2 diabetes mellitus with diabetic neuropathy, chronic pulmonary edema,
unspecified glaucoma, and acute kidney failure.
Review of Resident #1's physician order dated 7/23/2023 reads, Low Concentrated Sweets/NAS (No
Added Salt) diet. Regular texture, thin consistency.
Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution
pen-injector. Inject 20 unit subcutaneously at bedtime related to type 2 diabetes mellitus with diabetic
neuropathy, unspecified.
Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution
pen-injector. Inject 60 unit subcutaneously one time a day related to type 2 diabetes mellitus with diabetic
neuropathy, unspecified.
Review of Resident #1's care plan did not reveal a focus area for diabetes.
During an interview on 10/13/2023 at 2:05 PM, the Minimum Data Set Coordinator stated, [Resident #1's
name] should have been care planned for diabetes since April [2023]. I do not know how it was missed.
Review of the facility policy and procedure titled Person Centered Care Planning with the last review date of
12/20/2022 reads, An individualized comprehensive care plan will be person centered and must include
measurable objectives and timetables that meet the resident's medical nursing, mental, and psychosocial
needs. The care plan will consider the whole person, taking into account each resident's unique qualities,
abilities, interests, preferences, and needs.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105717
If continuation sheet
Page 3 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105717
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/13/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Timberridge Nursing & Rehabilitation Center
9848 SW 110th St
Ocala, FL 34481
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review and interview, the facility failed to ensure the medical records were accurate for blood sugar
levels for 1 of 3 residents reviewed for diabetes, Resident #1.
Findings include:
Review of Resident #1's admission record showed the resident was most recently admitted on [DATE] with
diagnoses to include type 2 diabetes mellitus with diabetic neuropathy, chronic pulmonary edema,
unspecified glaucoma, and acute kidney failure.
Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution
pen-injector. Inject 20 unit subcutaneously at bedtime related to type 2 diabetes mellitus with diabetic
neuropathy, unspecified.
Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution
pen-injector. Inject 60 unit subcutaneously one time a day related to type 2 diabetes mellitus with diabetic
neuropathy, unspecified.
Review of Resident #1's Medication Administration Record for October 2023 revealed no blood sugar level
documented at 9:00 PM on 10/1/2023 through 10/8/2023 for administration of 20 units of Basaglar KwikPen
100 Unit/ML Solution pen-injector at bedtime.
Review of Resident #1's Medication Administration Record for October 2023 revealed no blood sugar level
documented at 8:00 AM on 10/1/2023 through 10/3/2023 for administration of 60 units of Basaglar KwikPen
100 Unit/ML Solution pen-injector one time a day.
Review of Resident #1's Medication Administration Record for September 2023 revealed no blood sugar
level documented at 8:00 AM on 9/26/2023 through 9/30/2023 for administration of 60 units of Basaglar
KwikPen 100 Unit/ML Solution pen-injector one time a day.
Review of Resident #1's Medication Administration Record for September 2023 revealed no blood sugar
level documented at 9:00 PM on 9/26/2023 through 9/30/2023 for administration of 20 units of Basaglar
KwikPen 100 Unit/ML Solution pen-injector at bedtime.
During an interview on 10/13/2023 at 12:35 PM, the Assistant Director of Nursing stated, I do not know
what happened in the lapse of time; Why the order did not trigger for the blood sugars to be documented.
Normally, it would trigger a section where the nurse records the blood sugars. I would have to see if there
were any refusals or if there was a change in medication.
Review of the facility policy and procedure titled Documentation, Clinical with the last review date of
12/20/2023 reads, Purpose: The facility clinical staff will document the provision of care and services
according to nursing standards and regulatory requirements. When completed, documentation will
accurately reflect the clinical care and other services provided to the resident and ensure that the
appropriate information is available to all interdisciplinary team members. Documentation in the medical
record of each resident should provide: 1. A complete account of the resident's care treatment and
response to the care.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105717
If continuation sheet
Page 4 of 4